Hamman-Rich syndrome epidemiology and demographics: Difference between revisions

	Hamman-Rich syndrome Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Hamman-Rich syndrome from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Hamman-Rich syndrome epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Hamman-Rich syndrome epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hamman-Rich syndrome epidemiology and demographics
CDC on Hamman-Rich syndrome epidemiology and demographics
Hamman-Rich syndrome epidemiology and demographics in the news
Blogs on Hamman-Rich syndrome epidemiology and demographics
Directions to Hospitals Treating Hamman-Rich syndrome
Risk calculators and risk factors for Hamman-Rich syndrome epidemiology and demographics

Revision as of 19:28, 22 March 2018

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chandrakala Yannam, MD [2]

The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.

The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
The prevalence of [disease/malignancy] is estimated to be [number] cases annually.

In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
The case-fatality rate/mortality rate of [disease name] is approximately [number range].

Acute interstitial pneumonitis occur typically previously healthy individuals in the age group of 50 to 55years.^[1]

[Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].

↑ Vourlekis JS, Brown KK, Cool CD, Young DA, Cherniack RM, King TE, Schwarz MI (November 2000). "Acute interstitial pneumonitis. Case series and review of the literature". Medicine (Baltimore). 79 (6): 369–78. PMID 11144035.

@@ Line 19: / Line 19: @@
 ===Age===
-*Patients of all age groups may develop [disease name].
+*Acute interstitial pneumonitis occur typically previously healthy individuals in the age group of 50 to 55years.<ref name="pmid11144035">{{cite journal |vauthors=Vourlekis JS, Brown KK, Cool CD, Young DA, Cherniack RM, King TE, Schwarz MI |title=Acute interstitial pneumonitis. Case series and review of the literature |journal=Medicine (Baltimore) |volume=79 |issue=6 |pages=369–78 |date=November 2000 |pmid=11144035 |doi= |url=}}</ref>
-*The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
-*[Disease name] commonly affects individuals younger than/older than [number of years] years of age.
-*[Chronic disease name] is usually first diagnosed among [age group].
-*[Acute disease name] commonly affects [age group].
 ===Race===